ChitogenX Inc.
CHGX
Clasificación en acciones
#39856
ChitogenX Inc. is a Canadian biologics firm specializing in orthopaedic and... ChitogenX Inc. is a Canadian biologics firm specializing in orthopaedic and sports medicine. The company is dedicated to the research and development of innovative therapeutic technologies designed to improve the success rates of soft tissue repair in sports medicine surgeries. Its product pipeline features several biomaterial-based treatments, including Ortho-R for rotator cuff repair, Ortho-M for meniscus repair, and Ortho-C for articular cartilage repair. Additionally, they are developing Ortho-V to address osteoarthritis healing and ORTHO-T for tendon regeneration. Established in 2015, the company underwent a name change from Ortho Regenerative Technologies Inc. to ChitogenX Inc. in September 2022. It maintains its headquarters in Kirkland, Canada.
Precio por acción
$0.00365786
Última sincronización: 2025-07-07
Capitalización bursátil
$293.82K
Cambio (1 día)
-0.43%
Cambio (1 año)
-28.28%
País
CA
Comercio ChitogenX Inc. (CHGX)
Categoría
Healthcare
Historial del precio de la acción de ChitogenX Inc. (CHGX)
Precio más alto de cierre: $0.01 el 2026-10-01
Precio más bajo de cierre: $0.46 el 2020-10-01
Precio más bajo de cierre: $0.46 el 2020-10-01
Historial del precio de la acción de ChitogenX Inc. desde 2020 hasta 2026
Desempeño anual del precio de la acción
| Año | Rendimiento |
|---|---|
| 2026 (TTM) | 0.00% |
| 2025 | -53.93% |
| 2024 | -85.54% |
| 2023 | -64.19% |
| 2022 | -43.64% |
| 2021 | -43.08% |
| 2020 | 0.00% |
Precio de la acción de empresas similares o competidoras
| Empresa | Precio de la acción | Cambio 1a% | País |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $764.76 | 8.70% |
CH
|
